Healios K.K. is a biotechnology company based in Tokyo, Japan, specializing in the development of innovative regenerative medicine therapies. The company focuses on harnessing the potential of stem cells and other advanced biological technologies to address unmet medical needs, particularly in the fields of neurology and oncology. Healios is committed to advancing its research and development efforts to create effective treatments that improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#1,914 in Tokyo

#4,400 in Japan

#55,986 in the World

Tokyo, Japan

Healios K.k.

Forward Citations = 3

14 inventors:

Takao Kuroda (3 out of 30 patents)

Satoshi Ando (2 out of 60 patents)

Masayo Takahashi (2 out of 19 patents)

4. Kiyotoshi Sekiguchi (2 out of 18 patents)

5. Masanori Sawada (2 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Healios K.k.. Retrieved from https://idiyas.com/company/healios-k-k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]